Delivery Order SPE2DB20D3103-SPE2DB25FL3R9
Award Date
10/15/24
Potential Completion Date
11/5/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,605.44 firm-fixed-price contract is for the supply of 250 mg vials of the drug Ryanodex, with a completion date of July 2, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567771250 RYANODEX 250 MG VIALS. The contract has a ceiling value of $3,210.88 and a period of performance through April 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $1,489.63 and an ultimate completion date of September 4, 2024. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen's Corporate Office Division, which is a for-profit organization, will be performing the contract at a location in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract has a ceiling value of $5,958.56 and a period of performance through September 30, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $3,210.88 and a period of performance through April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,605.44 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $3,210.88 and a period of performance through June 4, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ryanodex 250 mg vials. The delivery order, valued at $4,468.92, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the U.S. Department of Defense, delivering a wide range...
This federal contract award, valued at $1,489.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, with a completion date of July 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...